DECIMMUNE THERAPEUTICS INC has a total of 17 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and biotechnology are MAB DISCOVERY GMBH, ALECTOR LLC and APTEVO RES & DEVELOPMENT LLC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Peptides | |
#3 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Puro Robyn J | 8 |
#2 | Carroll Elisabeth | 7 |
#3 | Robyn J Puro | 1 |
#4 | Haas Michael S | 1 |
Publication | Filing date | Title |
---|---|---|
AU2015202351A1 | Anti-inflammatory antibodies and uses therefor | |
US2014271628A1 | Humanized, anti-N2 antibodies | |
WO2014055392A2 | Method of protecting cardiac function | |
WO2011071883A1 | Anti-inflammatory antibodies and uses therefor |